We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dozens Of States Probe Abilify Marketing

Law360 (April 28, 2009, 12:00 AM EDT) -- A 38-state coalition has launched an investigation into Bristol-Myers Squibb Co. for alleged violations of state consumer protection laws in its marketing of anti-psychotic Abilify.

In a 10-Q form filed Tuesday with the U.S. Securities and Exchange Commission, the company disclosed the existence of the multistate investigation into its marketing of Abilify, an anti-psychotic.

In March, Bristol-Myers received a letter from the Delaware Attorney General's Office notifying it of the investigation, it said in the filing.

Bristol-Myers did not disclose details of the investigation in the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.